Eisai Co., Ltd. (TYO:4523)
Japan
· Delayed Price · Currency is JPY 4,821.00
-39.00 (-0.80%)
At close: Mar 9, 2026
Eisai Company Description
Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals.
It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas.
The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955.
Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Eisai Co., Ltd.
| Country | Japan |
| Founded | 1941 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 10,917 |
| CEO | Haruo Naito |
Contact Details
Address: 4-6-10 Koishikawa Tokyo, 112-8088 Japan | |
| Phone | 81 3 3817 3700 |
| Website | eisai.co.jp |
Stock Details
| Ticker Symbol | 4523 |
| Exchange | Tokyo Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | JPY |
| ISIN Number | JP3160400002 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Haruo Naito | Chief Executive Officer |
| Takuya Oyama | Chief Financial Officer |
| Keisuke Naito | Chief Operating Officer |
| Takuya Oyama | Head of Investor Relations |